小剂量倍他乐克治疗充血性心力衰竭对血浆脑钠尿肽水平的影响(PDF)
《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]
- 期数:
- 2005年第2期
- 页码:
- 140-141/144
- 栏目:
- 临床研究
- 出版日期:
- 2005-03-05
文章信息/Info
- Title:
- Effect of low dose Betaloc on plasma brain natriuretic peptide level in patients with congestive heart failure
- Author(s):
- SUN Jing; QIAN Anbin
- Department of Medicine， Ningbo First Hospital,Ningbo, Zhejiang 315010， China
- Keywords:
- brain natriuretic peptide ; betaloc ; heart failure; congestive
- 分类号:
- R541.61
- DOI:
- -
- 文献标识码:
- A
- 摘要:
- 目的 观察小剂量倍他乐克治疗充血性心力衰竭（CHF）后,患者血浆脑钠尿肽(BNP)水平的改变。方法 选择心功能Ⅲ～Ⅳ级心衰患者31例,在常规抗心衰基础上加用小剂量倍他乐克,观察治疗前后血浆BNP水平的变化。结果 心率明显减慢, 心胸比和血压均较治疗前降低, 左室舒张末期内径(ＬＶＤｄ)缩短,左室射血分数(ＬＶＥＦ)则较治疗前提高, BNP值显著降低，总有效率达81%。结论 小剂量倍他乐克治疗CHF可使BNP值显著下降, 动态监测患者血浆BNP水平有助于了解CHF治疗效果及预后。
- Abstract:
- AIM To observe plasma brain natriuretic peptide level of patients with congestive heart failure (CHF) treated with low dose Betaloc. METHODS We chose 31 heart failure patients with Ⅲ～Ⅳ New York Heart Association (NYHA)functional classification,and used low dose Betaloc on the basis of traditional treatment,then observed the change in plasma brain natriuretic peptide level during the treatment. RESULTS After the treatment,patients' heart rate, blood pressure， cardiothoracic ratio and ＬＶＤｄ all declined,but ＬＶＥＦ increased. The value of BNP declined obviously, and the total effective rate was 81%.CONCLUSION The value of BNP declined obviously after the use of the Betaloc, which may help to detrmine the therapeutic effect and prognosis for CHF.
参考文献/References
［1］ Packer M,Bristow WR. Effect of carvedilol on morbidity and mortality inchronic failure［J］. N Engl J Med,1996,334(6):1349.
［2］ Maisel AS, Krishnaswamy P, Nowak R. et al. Rapid measurement of Btype natriuretic peptide in the emergency diagnosis of heart failure［J］. N Engl J Med,2002,347(14):1126.
［3］ Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death［J］. N Engl J Med,2004,350(7):665-663.
［4］ Maeda K,Takayoshi T,Wada A， et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular enddiastolic pressure in patient with symptomatic left ventricular dysfunction［J］. Am Heart J,1998,135:825-832.
［5］朱妙章，袁文俊，吴博威，等. 心血管生理学与临床［M］. 北京：高等教育出版社，2004.138,451.
［6］ Sudoh T, Maekawa K, Kojima M,et al. Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide［J］. Biochem Biophys Res Commun, 1989,159:1427-1434.
［7］ Luchner A, Stevens TL, Borgeson DD, et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure［J］. Am J Physiol, 1998,274:H1684-H1689.
［8］ Harrison A, Morrison LK, Krishnaswamy P, et al. Btype natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea［J］. Ann Emerg Med, 2002,39:131-138.
［9］ Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of Btype natriuretic peptide in comparison with those of Atype natriuretic peptide in normal subjects and patients with heart failure［J］. Circulation, 1994,90:195-203.
［10］Groenning BA, Nillsson JC, Sondergaard L, et al. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentratrions［J］. European Journal of heart failure,2001,3:699-708.
［11］ Mottram PM, Leano R, Marwick TH. Usefulness of Btype natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function［J］. Am J Cardiol,2003,92(12):1434-1438.
［12］赵丽，吴学思，韩智红，等．B型利钠肽对心力衰竭患者的临床评估［J］. 中华心血管病杂志,2004,32:51-52．
备注/Memo
- 备注/Memo:
- 收稿日期：2004-06-28.
常用功能
统计/Statistics
- 摘要浏览/Viewed1088
- 全文下载/Downloads665
- 评论/Comments
